Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Aktietilbagekøbsprogram i Alm. Brand A/S Transaktioner 2. september 2024 – 6. september 2024Alm. Brand A/S offentliggjorde i selskabsmeddelelse nr. 40/2024 et aktietilbagekøbsprogram på op til 150...
-
Alm. Brand A/S share buy-back program Transactions during 2 September 2024 – 6 September 2024On 15 August 2024, Alm. Brand A/S announced a share buy-back program of up to DKK 150 million, as...
-
Selskabsmeddelelse nr. 40 2024 Group CommunicationsBernstorffsgade 40DK-1577 København VTel. +45 45 14 00 009. september 2024 Aktietilbagekøb i Danske Bank: Transaktioner i uge 36 Den 2. februar 2024...
-
Company announcement no. 40 2024 Group CommunicationsBernstorffsgade 40DK-1577 København VTel. +45 45 14 00 009 September 2024 Danske Bank share buy-back programme: Transactions in week 36 On 2...
-
New York, United States , Sept. 09, 2024 (GLOBE NEWSWIRE) -- The Global Chemical Catalyst Market is to Grow from USD 40.52 Billion in 2023 to USD 64.10 Billion by 2033, at a Compound Annual Growth...
-
Aktietilbagekøbsprogrammet løber i perioden fra og med den 3. juni 2024 til senest den 31. januar 2025. I denne periode vil Jyske Bank erhverve egne aktier til en maksimal værdi af 1,5 mia. kroner i...
-
The share repurchase programme runs as from 3 June 2024 and up to and including 31 January 2025. In this period, Jyske Bank will acquire shares with a value of up to DKK 1.5 billion, cf. Corporate...
-
SAMPO PLC STOCK EXCHANGE RELEASE 9 September 2024 at 8:30 am Sampo plc’s share buybacks 6 September 2024 On 6 September 2024, Sampo plc (business code 0142213-3, LEI...
-
ROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...
-
Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity Investor Webcast to be Held Friday, September 13, 2024 at 12:00 pm ET ...